Patent details

EP3049112 Title: INFLUENZA VACCINE AND THERAPY

Basic Information

Publication number:
EP3049112
PCT Application Number:
US2014056703
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP148455660
PCT Publication Number:
WO2015042498
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
INFLUENZA VACCINE AND THERAPY
French Title of Invention:
VACCIN ET TRAITEMENT CONTRE LA GRIPPE
German Title of Invention:
INFLUENZAIMPFSTOFF UND THERAPIE
SPC Number:

Dates

Filing date:
21/09/2014
Grant date:
09/09/2020
EP Publication Date:
03/08/2016
PCT Publication Date:
26/03/2015
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
09/09/2020
EP B1 Publication Date:
09/09/2020
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
21/09/2020
Expiration date:
21/09/2034
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
05/03/2021
 
 

Name:
Engen Bio, LLC
Address:
61 Avondale Avenue, Redwood City, CA 94062, United States (US)

History of Owners

From:
02/09/2020
To:
05/03/2021

Name:
Engen Bio, Inc.
Address:
61 Avondale Avenue, Redwood City, CA 94062, United States (US)

Inventor

1

Name:
BUCHER, Doris
Address:
United States (US)

2

Name:
ALFENITO, Mark
Address:
United States (US)

3

Name:
BAER, Mark
Address:
United States (US)

Priority

Priority Number:
201361881325 P
Priority Date:
23/09/2013
Priority Country:
United States (US)

Classification

IPC classification:
A61K 39/395;

Publication

European Patent Bulletin

1

Issue number:
202037
Publication date:
09/09/2020
Description:
Grant (B1)

2

Issue number:
202114
Publication date:
07/04/2021
Description:
Transfer of Rights

Annual Fees

Annual Fee Due Date:
Annual Fee Number:
Expected Payer:
Last Annual Fee Payment Date:
Last Annual Fee Paid Number:
Payer:
Filing date Document type Number of pages